Lab equipment in the focus of view
Products & Prices
Page 3 from 4
Head office
Dateascending News
15.07.02 S2 Ranger:
- As far as we know the S2 system is assembled in Congleton, UK
- We are not sure where the detector originates. Would like to get more input on this.
- Their 50-Watt tube comes from Varian.
15.05.02 Bruker participated in the EPDIC in Sweden.
10.05.02 New Bruker organisation in Japan: Mac Science closed their Kaga Factory and moved to a new building in Tokyo. They have stopped producing all products except the rotating anode generator. Nihon Bruker ASX KK will now be called Bruker AXS KK.
05.05.02 Bruker AXS Announces Profitable First Quarter 2002 With 26% Revenue Increase
May 9, 2002 5:03pm
Bruker AXS Inc., (NASDAQ: BAXS), a leading global provider of advanced X-ray solutions for the life and advanced materials sciences, today reported its financial results for the first quarter 2002.
Net sales for the three months ended March 31, 2002 increased 26% to $23.8 million, compared to $18.8 million for the three months ended March 31, 2001. After elimination of unfavorable currency effects, revenue growth was 31%.
Net income for the first quarter of 2002 was $0.3 million, or $0.01 per share, compared to $0.00 per share for the first quarter of 2001.
Cash and cash equivalents totaled $53.1 million as of March 31, 2002.
Dr. Martin Haase, President and CEO, stated: "We are very pleased to announce another successful quarter of growth and operating improvements. We exceeded our expectations this quarter for both revenue growth and EBIT. "Later this year we anticipate several new product introductions targeted at the life-science market that should further contribute to our growth objectives," added Dr. Haase. "Furthermore, the recently announced acquisition of MAC Science strengthens our position in the large Japanese market, which is estimated to account for more than 25% of the world X-ray analysis market. With the integration of MAC Science's excellent compact X-ray source technology, we expect to gain market share in this very important region."
"Our healthy backlog provides good top-line visibility for the second quarter and into the third quarter of 2002," said Laura Francis, Chief Financial Officer. "In accordance with previous guidance for the year 2002, we expect robust organic revenue growth of greater than 15%, and earnings per share of $0.03, after the effects of the MAC Science acquisition."
15.04.02 Bruker AXS Acquires MAC Science to Further Penetrate Japanese Life Science and Materials Research Markets.

MADISON, Wis.--(BUSINESS WIRE)--April 18, 2002--Bruker AXS Inc. BAXS, a leading global provider of advanced X-ray solutions for the life and advanced materials sciences, today announced that its wholly owned Japanese subsidiary, Nihon Bruker AXS K.K., has signed a binding agreement to acquire substantially all the assets and certain liabilities of MAC Science Ltd., a Yokohama, Japan-based company focused on X-ray analysis instrumentation. The transaction is expected to close in the second quarter of 2002.

MAC Science was founded in 1987, and has become a significant participant in the Japanese X-ray and thermal analysis instrumentation market. The Japanese X-ray analysis market is estimated to total more than $150 million annually. MAC Science has an established Japanese distribution system with both a direct sales and a service force, as well as an additional distributors network. Since its foundation, MAC Science has installed more than 1,500 systems in Japan and the Pacific Rim.

Bruker AXS entered the Japanese market in 1997 with its CCD-based life-science systems, and has established a strong position in the crystallography market. The new combined business will be located in the Tokyo area to provide strong sales, applications and service support for the existing and future customers of Bruker AXS and MAC Science. The new facility will also house R&D, production and final systems integration for the Japanese market.
Dr. Martin Haase, President and CEO of Bruker AXS, said: "The good market position of MAC Science and its excellent compact X-ray source technology will allow us to further penetrate the large Japanese analytical X-ray market, which we estimate to account for more than 25% of the total world market. Having R&D and an assembly line close to our customers in Japan will enhance our ability to meet their demanding product and support requirements."

"We expect this acquisition to add approximately $2 million to our quarterly revenue, starting in the fourth quarter of 2002," continued Ms. Laura Francis, new CFO of Bruker AXS. "We anticipate that in 2003, this revenue component will begin to grow at our overall revenue target growth rate of greater than 15% per annum. In 2002, we estimate that this acquisition will have a dilutive effect on EPS of approximately $0.02 per share whereas in 2003 we do not expect any dilutive effect of the MAC Science acquisition. We anticipate that by 2004 the MAC Science acquisition will become accretive to our earnings."
Frank H. Laukien, Chairman of Bruker AXS, commented: "I expect that the combined business will give us the critical mass to grow our Japanese business significantly, and that we can become one of the top two players in advanced x-ray solutions in Japan. We believe this acquisition is a great strategic fit for Bruker AXS, and an excellent use of our IPO proceeds. The MAC Science acquisition will grow our technology and customer base, and should further accelerate our revenue and earnings growth."
Mr. Sadao Ueki, President of Nihon Bruker AXS KK, added: "The business combination of Bruker AXS and MAC Science will enable us to significantly broaden our presence in Japan. The dedicated MAC Science management team and employees will integrate well with our existing organization. I am excited about this transaction and foresee an excellent business opportunity for our combined forces."
Mr. Hideo Ohta of MAC Science, Technical Director of the future MAC Science Division of Bruker AXS, stated: "Bruker AXS has an excellent and very innovative product portfolio. When combined with our technologies and market know-how, we expect to become an important presence in the attractive Japanese analytical X-ray market. Our management team and employees are excited to join Bruker AXS. The Bruker AXS strategy to provide innovative technology-leading solutions and high-level in-country support for our customers will be a strong foundation for success."
15.03.02 Introduction of the S2 Ranger a bench top EDXRF unit. The unit is assembled in Congleton, UK. According Bruker, the system is introduced mainly versus Spectro !!!!
First issue of their new bulletin called : EDX News
Congleton appears to be their new EDX headquarters
15.02.02 Bruker AXS Announces Technology joint venture for innovative X-ray optics based on innovative coating technologies. A s part of the joint venture, Bruker AXS will hold 51% stake in INCOATEC GmbH, a German company that was spun off from the GKSS, a materials research centre located in Geesthacht, Germany.
This joint venture further enhances our already broad in-house technology portfolio, and allows us to drive development of next generation optics for our life sciences and materials science systems, GKSS will licence its relevant patents to INCOATEC, which will be manager by Dr Carsten Michaelsen and Dr Joerg Wiesmann.
Bruker AXS will exclusively market the INCOATEC products through its established global distribution organisation, and will provide capital and R&D resources to optimise the use of these optics in the field of X-Ray instrumentation
15.12.01 Introduction of the S4 Pioneer.
The very compact S4 PIONEER high power 4 kW sequential X-ray Spectrometer provides the best analytical performance in short measuring time.
15.11.01 Bruker has filed for an IPO of common stock that could raise as much as $100 million AXS is concentrating on the growth industries of drug discovery and development with its integrated solutions for protein structure determination via X-ray crystallography, a market that totalled approximately $1Billion in 2000 and is expected to increase by 40% per year to $5,6Billion in 2005 With the acquisition of X-ray diffraction specialist Nonius BV in April this year, AXS has secured X-ray source technology and according to the company, positioned itself as the leader for small molecule diffraction instrumentation supplying 80% of instruments" for this market.
15.04.01 Bruker AXS has bought the X-ray diffraction company Nonius BV from Delft Instruments in a move to acquire "critical mass" and be the leading supplier to the protein X-ray crystallographic market. Bruker will establish Nonius in Delft as the European headquarters for Bruker AXS with R&D and production facilities
1 2 3 4

002505 Powered by DSGroup | version 2.0 | © neoLab.ru 1998-2024